Evoq Remedies Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹0(0.00%)
Premium (ELP)
The public market debut of Evoq Remedies Limited's was completed on Mar 30, 2022 with its listing on the BSE exchange. The IPO process raised 36,00,000 Shares in total capital, consisting of 36,00,000 Shares in new equity.
The offering featured a price range of ₹27 to ₹27 and minimum application size of 4000 shares. Investor response during the subscription period from Mar 17, 2022 to Mar 22, 2022 influenced the final allotment ratios across investor categories.
Final allotment was announced on Mar 28, 2022, distributing shares to successful subscribers. The listing established a continuous market for the company's shares, enabling liquidity, valuation transparency, and broader investor participation.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Founded in 2010, EVOQ Remedies Limited provides high-quality pharmaceutical raw materials, excipients, and bulk drugs at affordable prices. The company sources its products from trusted WHO-GMP certified manufacturers and importers, ensuring they meet strict national and international quality standards.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Experienced Management: Led by a skilled and knowledgeable leadership team.
- Strong Client Trust: Builds and maintains long-term relationships with customers.
- Quality at Fair Prices: Delivers high-quality products at reasonable prices.
NA
- Mr. Bhumishth Narendrabhai Patel
- Mrs. Payal Bhumishth Patel
Evoq Remedies Limited
Bigshare Services Private Limited